Search Blog
Categories
May 2018
M T W T F S S
« Apr    
 123456
78910111213
14151617181920
21222324252627
28293031  

Tags

Nutanix, Inc. Class A to Host Earnings Call

By Investor Network

NEW YORK, NY / ACCESSWIRE / May 24, 2018 / Nutanix, Inc. Class A (NASDAQ: NTNX) will be discussing their earnings results in their Q3 Earnings Call to be held on May 24, 2018 at 4:30:00 PM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/83199

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the companys profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 500682

Gap, Inc. to Host Earnings Call

By Investor Network

NEW YORK, NY / ACCESSWIRE / May 24, 2018 / Gap, Inc. (NYSE: GPS) will be discussing their earnings results in their Q1 Earnings Call to be held on May 24, 2018 at 5:00 PM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/1705.

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 500687

Agilysys, Inc. to Host Earnings Call

By Investor Network

NEW YORK, NY / ACCESSWIRE / May 24, 2018 / Agilysys, Inc. (NASDAQ: AGYS) will be discussing their earnings results in their Q4 Earnings Call to be held on May 24, 2018 at 4:30 PM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/23349.

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 500684

8×8, Inc. to Host Earnings Call

By Investor Network

NEW YORK, NY / ACCESSWIRE / May 24, 2018 / 8×8, Inc. (NYSE: EGHT) will be discussing their earnings results in their Q4 Earnings Call to be held on May 24, 2018 at 4:30 PM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/23349.

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 500685

InvestmentPitch Media Video Discusses Naturally Splendid’s Engagement of Dr. Janmohamed as Qualified Person in Charge for Cannabis Dealers License Application – Video Available on InvestmentPitch.com

Vancouver, British Columbia–(Newsfile Corp. – May 24, 2018) – Naturally Splendid Enterprises (TSXV: NSP) (FSE: 50N) (OTCQB: NSPDF) has engaged Dr. Amin Janmohamed as its Qualified Person In Charge in the company’s application to become a Licensed Dealer. He has also joined Naturally Splendid’s Advisory Board where his extensive medical research and formulation experience will be a significant asset as strategic plans continue to evolve and focus on the nutraceutical and therapeutic applications for cannabinoids such as CBD and THC.

InvestmentPitch Media has produced a “video” which describes this news. If this link is not enabled, please visit www.InvestmentPitch.com and enter “Naturally Splendid” in the search box.

Cannot view this video? Visit:
http://www.investmentpitch.com/video/0_idtyp68l/Naturally-Splendid-TSXVNSP-engaged-Dr-Amin-Janmohamed-as-its-QPIC-in-the-companys-application-to-become-a-Licensed-Dealer

Dr. Janmohamed, a researcher, clinical program developer and drug formulator in the area of severe opioid use disorder, has been published in several medical publications. He brings extensive expertise in formulations, regulations, drug development, manufacturing, security, and program development of controlled substances in clinical trials and clinical treatment.

Currently a researcher at the Centre for Health Evaluation and Outcome Sciences “CHEOS” affiliated with Providence Health Care Research Institute and UBC Faculty of Medicine, Dr. Janmohamed is also the CEO of Bixa Therapeutics Inc., Bixa Research Inc., and Bixa S.A., and a co-investigator in the Study to Access Long-term Opioid Medication “SALOME” clinical trial.

Douglas Mason, CEO, stated: “Engaging Dr. Janmohamed as our QPIC is a critical step towards Naturally Splendid becoming a Licensed Dealer in Canada. With his first-hand experience at obtaining and working under a Dealer’s License and his many years of research experience, he will be able to guide us through the process and provide invaluable insight. He has a wealth of history in the medical research and formulation field that will be invaluable on our Advisory Board as we pursue a number of activities related to cannabis and the extraction, formulation and distribution of cannabinoids.”

Becoming a Licensed Dealer creates the opportunity for several revenue streams including CBD and THC as well as other cannabinoids derived from hemp or marijuana, as it relates to extraction, distillation, product development, manufacturing, packaging, and marketing of cannabinoid fortified products.

According to the Prime Minister’s office, regulatory laws in Canada pertaining to the extraction of CBD from industrial hemp are anticipated to be amended in the summer of 2018. Becoming a Licensed Dealer positions Naturally Splendid to be a supplier of cannabis extracts and cannabis extract fortified products as well as importing and exporting globally.

Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products.

The company recently acquired Absorbent Concepts Inc., an organic hemp processor, located in Abbotsford, British Columbia. Listed as the only strictly organic hemp seed processor in North America, ACI is a significant producer of hulled seed, hemp seed oil and high percentage protein powder, sold under the OmegaVida brand, with plans to expand to provide a full range of conventional hemp products.

For more information please visit the company’s website www.naturallysplendid.com, or contact investor relations at 604-673-9573 or email info@naturallysplendid.com.

About InvestmentPitch Media

InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company’s story ahead of the 1,000’s of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news, research reports and other content of interest to its following of retail, institutional and accredited investors.

CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com

Medical Marijuana Clinic Expands to Fort Myers and Naples

By Liberate Physician Centers/Fort Myers and Naples

FORT MYERS and NAPLES, FL / ACCESSWIRE / May 24, 2018 / Liberate Physician Centers, a medical marijuana certification center and clinic, has expanded its Florida operations by opening new offices in Fort Myers and Naples, joining previous clinics in Jacksonville, Port Charlotte and West Palm Beach as part of the Liberate network.

The new offices are headed by Robert Brueck, MD serving as Medical Director and Don Ketterhagen, MD serving as Operations Director. The Fort Myers location is 8646 Gladiolus and the Naples location is 1250 9th Street North. The phone numbers are 239-202-0606 and 239-659-2777, respectively.

“We are very pleased to add these two clinic offices to serve Floridians in need of medical marijuana therapy,” says Daniel J. Reid, founder and chief executive officer of Liberate. “These new locations will give residents of Southwest Florida convenient access to patients in need of this important medicine.

“Cannabis is often an ideal therapy for people suffering from chronic illness and disease,” says Brueck. “Our process for qualifying patients is designed to make it easier to obtain access and remain in compliance with Florida law.”

Liberate was founded in 2013 with a flagship office in Michigan and an operations center in Colorado. The company was the first medical marijuana business in the state of Florida, having opened in West Palm Beach in 2015 in anticipation of the passage of Amendment 2 on the November 2016 ballot.

“Our approach in Florida is highly localized,” says Reid. “Each office has local physicians and local management, along with access to national experts in medical marijuana therapy, physician office management, cannabis law and regulation, compliance and best practices.”

Reid’s advice to patients that think they might benefit from medical marijuana therapy is simple and direct: “We tell patients to Get Legal, Get Help, and Get Started because the process in Florida requires a physician and ongoing care. Liberate has extensive experience in Florida and nationally and is ideally suited to help patients in becoming legal cardholders.”

FOR FURTHER INFORMATION:

Don Ketterhagen
239-336-9882
ketter@liberateFM.com

Daniel J. Reid
312-316-4313
dreid@liberatepc.com

SOURCE: Liberate Physician Centers/Fort Myers and Naples

ReleaseID: 500805

DEADLINE ALERT – Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action Against Solid Biosciences Inc. (SLDB) & Lead Plaintiff Deadline – May 28, 2018

By Bronstein, Gewirtz and Grossman, LLC

NEW YORK, NY / ACCESSWIRE / May 24, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Solid Biosciences Inc.(“Solid” or the “Company”) (NASDAQ: SLDB) and certain of its officers, on behalf of shareholders who purchased Solidsecurities (1) in Solid’s initial public offering on or about January 25, 2018; or (2) on the open market from January 25, 2018 through March 14, 2018, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/sldb.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.

The complaint alleges that throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) Solid’s lead drug candidate, SGT-001, had a high likelihood of causing adverse events in patients; (2) The company misled investors regarding the toxicity of SGT-001; and (3) consequently, defendants’ statements in the Registration Statement regarding Solid Biosciences’ business, operations, and prospects were materially false and/or misleading.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/sldbor you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Solid you have until May 28, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 500730

Alternet Systems Announces Lithium Technology Military Application Strategy Presentation

By Alternet Systems, Inc.

DALLAS, TX / ACCESSWIRE / May 24, 2018 / Alternet Systems, Inc. (OTC PINK: ALYI) today announced releasing an online presentation on the company’s website to provide an overview of the company’s current strategy to integrate its portfolio of lithium battery technology into energy solutions to support combat systems. Alternet concentrates defense industry sales efforts on developing partnerships with the approved government contractors that account for more than $250 Billion in annual US defense spending. The narrative from the presentation is included in its entirety below. This presentation was originally scheduled to be released yesterday, but was delayed due to unanticipated schedule conflicts.

Alternet Systems Business Development Strategy To Integrate Its Portfolio Of Lithium
Technology Into Combat Solutions

The United States Military uses a lot of lithium batteries. Do a Google search of “lithium-batteries-military” and you can read for days about the current applications of lithium batteries in the military; research the military is doing into improving upon current lithium battery technology, and multiple contracts signed procuring lithium batteries for the military. The US military spends over $100 million dollars a year on batteries. Now consider that there are 195 countries in the world (at last count) and only about 20 of them does not have a military. That’s a pretty big battery market and as military equipment becomes more electronic and more portable, that battery market is only going to grow.

As non-state sponsored militant organizations continue to grow and proliferate, such organizations will be focused on developing counter electronics to attack the electronic command and control systems of larger state-sponsored militaries. In turn, larger state-sponsored militaries will be looking to develop counter measures to prevent cyber-attacks. As the battlefield continues to evolve from invasion and defense campaigns toward surgical, and often covert strikes, demand for individual mobile electronic solutions will continue to grow. The military need for durable, sustainable and long-lasting self-contained power sources is only going to get bigger.

The management team at Alternet has first-hand experience with many of the military, special operations and clandestine uses of batteries. The management team is familiar with many of the vendors (most of which people have never heard of) that provide the military with current contained power solutions today. The most notable experience the Alternet management team brings is with the training operations conducted with small nation-states to empower those entities to support the United Nations consensus on allied sovereign authority. Accordingly, in addition to Alternet’s efforts to develop partnerships concentrating on the integration of Alternet technology into US combat systems, Alternet is also working to develop similar partnerships for delivering combat systems utilizing Alternet technology to small, allied nation-states. The US military industry sector is the largest exporter of military systems in the world accounting for over 30% of the entire defense sector market.

In addition to the ongoing business development efforts to partner with vendors to the US military, Alternet has engaged in a funded agreement to develop solutions in Africa. Non-state sponsored military organizations well-known in the middle east that have also masterminded notable attacks in Europe are also active in East Africa. The United States actively supports counterterrorism activities in East Africa. East African nations are both independently and with the support of the United States engaged in the battle against these well-known non-state sponsored military organizations. Alternet is actively engaged in the development of solutions that would integrate Alternet technology into systems intended to give counterterrorist forces an advantage. The engagement in Africa has the added benefit of being tangent to a separate effort to develop distribution opportunities for Alternet’s
ReVolt electric motorcycle in Africa
.

Learn more on the company’s website:
www.lithiumip.com

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.

Alternet Systems, Inc. Contact:

Randell Torno

info@lithiumip.com

1 800 713 0297

https://www.otc-alyi.com/contact/

SOURCE: Alternet Systems, Inc.

ReleaseID: 500806

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors It Filed a Complaint to Recover Losses Suffered by Aceto Corporation Investors and Set a Lead Plaintiff Deadline of June 25, 2018 — ACET

By Levi & Korsinsky, LLP

NEW YORK, NY / ACCESSWIRE / May 24, 2018 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired common stock of Aceto Corporation (NASDAQ: ACET) between August 25, 2017 and April 18, 2018. You are hereby notified that Levi & Korsinsky has commenced the class action Mulligan v. Aceto Corporation (Case No. 9:18-cv-02425) in the USDC for the Eastern District of New York. To get more information go to:

http://www.zlk.com/pslra-d/aceto-corporation?wire=1

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that (i) the Company failed to implement and enforce proper internal control to identify the misapplication of cash; (ii) the Company would incur large non-cash intangible asset impairment charges; (iii) the Company lacked effective internal control over financial reporting; (iv) the Company’s financial results for the fiscal year 2017 could not be relied upon; (v) the Company’s fiscal 2018 financial guidance was overstated; and (vi) as a result of the foregoing, Aceto’s public statements were materially false and misleading at all relevant times.

On April 18, 2018, Aceto issued a press release disclosing non-reliance on the previously issued 2018 fiscal year earnings guidance and the recording of non-cash intangible asset impairment charges, including goodwill, in the range of $230-$260 million.

If you suffered a loss in Aceto you have until June 25, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 500809

Hitachi High-Tech Launches a New Solution for the Rapid, On-Site Testing of Sulfur in Marine Fuel Oil

By Hitachi High-Tech Analytical Science

OXFORD, ENGLAND / ACCESSWIRE / May 24, 2018 / Hitachi High-Tech Analytical Science Corporation (Hitachi High-Tech Analytical Science), a Hitachi High-Technologies Corporation (TSE: 8036) wholly owned subsidiary engaged in the manufacture and sales of analysis and measuring instruments, has launched a new solution dedicated to the field-portable analysis of bunker fuel. The new X-MET8000 Optimum solution provides ship owners and port state control an alternative, portable option to benchtop XRF (X-ray Fluorescence) analysers to measure and monitor sulfur content in bunker fuel to meet the legislative requirements of the International Maritime Organisation’s global 2020 sulfur cap.

The X-MET8000 Optimum handheld XRF analyser can be easily taken from site to site and ship to ship. The instrument is factory-calibrated with a sulfur range of 0% to 5 % and calibrated to ASTM, D4294, IP336, and ISO8754. The solution also provides the end-user everything they need to carry out the analysis easily: sample cups, safety window and film, light stand and safety shield, and a brand new sample tray to keep the cup and safety window stable during the analysis. With the X-MET, you can achieve real-time data transfer with our IOS and Android apps, and cloud service. It also has an embedded GPS to pinpoint where the analysis was performed to provide compliance reporting.

The new X-MET8000 handheld XRF solution complements Hitachi High-Tech’s existing laboratory-based sulfur analysers, LAB-X and X-Supreme, to provide ship owners and port state control flexibility. Analysis can be carried out onboard a vessel by ship owners either using a benchtop or handheld XRF analyser, whilst port state control has the option of using benchtop analysers in laboratories and handheld analysers to perform spot-checks onboard vessels to ensure compliance.

Christelle Petiot, Hitachi Product Business Development Manager, said: “Ensuring compliance with the 2020 global sulfur cap regulation is a challenge for many organizations and for the industry. Onboard testing is the most effective method to establish compliance. We’ve got a long history working with testing houses in ports and laboratories. The launch of our X-MET8000 Optimum solution compliments our LAB-X benchtop analyser, which has been used over the last 20 years to test sulfur in the fuel. We’ve recently launched a new model, the LAB-X5000. It’s the fastest, easiest to use and most versatile model in the range’s 45-year history.

“Our launch of the LAB-X5000 and X-MET8000 Optimum solution demonstrates how we are constantly evolving our product ranges to ensure ship owners and port authorities are able to prove their compliance now and in the future.”

Hitachi High-Tech Analytical Science websites:

About Hitachi High-Technologies Corporation

Hitachi High-Technologies Corporation, headquartered in Tokyo, Japan, is engaged in activities in a broad range of fields, including Science and Medical Systems, Electronic Device Systems, Industrial Systems, and Advanced Industrial Products. The company’s consolidated sales for FY 2016 were approx. JPY645.5 billion [USD6 billion]. For further information, visit http://www.hitachi-hightech.com/global/.

About Hitachi High-Tech Analytical Science Corporation

Hitachi High-Tech Analytical Science is a new global company created in July 2017 within the Hitachi High Technologies Group. The company is headquartered in Oxford, UK, with research and development and assembly operations in Finland, Germany, and China and sales and support operations in a number of countries around the world. Our product range includes:

  • Our PMI-MASTER, FOUNDRY-MASTER and TEST-MASTER range of analysers are used by industries the world over for fast and precise metals analysis. Featuring optical emission spectroscopy technology, all important elements with low detection limits and high precision can be determined, including carbon in steel and all technically relevant main and trace elements in nearly all metals.
  • X-MET8000 handheld analysers, used by thousands of businesses to deliver simple, rapid and non-destructive analysis for alloy analysis, scrap metal sorting and metal grade screening using precision XRF technology.
  • Vulcan handheld analysers, with LIBS laser technology, identify metal alloys in just one second, making it one of the fastest analysers in the world. This hugely benefits businesses processing high volumes of metal.
  • FT series, X-Strata, Eco and MAXXI microspot XRF analysers measure coating thickness of single- and multi-layer coatings including alloy layers and are designed to be incorporated into quality control or process control programmes, as well as research laboratories.
  • Lab-X5000 and X-Supreme8000 benchtop XRF analysers deliver quality assurance and process control across a diverse range of industries such as petroleum, wood treatment, cement, minerals, mining, and plastics.

For Media Inquiries

Laura Phimister, Marketing Communications Manager, Hitachi High-Tech Analytical Science
Email: laura.phimister@hitachi-hightech-as.com

SOURCE: Hitachi High-Tech Analytical Science

ReleaseID: 500735